Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

…to my concern about this being yet another borderline statistically meaningless nano-trial.

I guess we’ll see, but a virologist with whom I spoke had mentioned the size and said ‘it would’ve been much more helpful if it’d been for 300 subjects or so’…

time will tell.

Hopefully bio markers in place will have favorable indications.

“In its letter, the FDA noted that so far, it has reviewed safety in only 131 randomized patients treated with ZYESAMI.”

https://www.prnewswire.com/news-releases/us-food-and-drug-administration-declines-emergency-use-authorization-for-zyesami-aviptadil-for-patients-with-critical-covid-19-with-respiratory-failure-301417228.html?fbclid=IwAR3_cYj8GViBA0asnnbjHH0kFfyXoeb4EyGaOZWqHmTWDmrpS8AWw3Y5Rg8

Note the use of the word “only”.

In IPIX’ study, only around 60 patients with COVID-19 will have received brilacidin.